BLOG

Saturday, June 20, 2020

Hetero set to launch Remdesivir under the brand name Covifor in India

The drug 'Remdesivir' has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children

from Home Page https://ift.tt/2zOH2IA
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...